SOUTHLAKE, Texas–(BUSINESS WIRE)–OncoNano Medicine, Inc. today announced it will be presenting data on two development candidates, as well as its ON-BOARD(TM) delivery platform, at the 37th Annual Meeting of the Society for Immunology of Cancer (SITC), taking place November 8-12, 2022 in Boston, Massachusetts. An oral and poster presentation by Dr. Qiang Feng detail new pre-clinical data for ONM-405, an IL-2-Fc construct formulated with OncoNano’s proprietary ON-BOARD(TM) polymeric-micelle delivery